Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Euro Surveill. 2020 Nov;25(44). doi: 10.2807/1560-7917.ES.2020.25.44.1900430.
BackgroundPoint-of-care tests (POCT) for influenza A and B viruses and respiratory syncytial virus (RSV) were implemented in emergency departments of all hospitals in the Capital Region of Denmark in 2018.AimTo establish whether POC testing for influenza viruses or RSV is based on a valid respiratory symptom indication, whether changes in patient management based on a positive result are safe and whether syndromic POC testing may benefit patients with influenza or RSV.MethodsSamples from 180 children (< 18 years) and 375 adults tested using POCT between February and July 2018 were retested for 26 respiratory pathogens. Diagnosis, indication for POC testing, hospitalisation time, antimicrobial therapy and readmission or death within one month of testing were obtained from patient records.ResultsA valid indication for POC testing was established in 168 (93.3%) of children and 334 (89.1%) of adults. A positive POCT result significantly reduced antibiotic prescription and median hospitalisation time by 44.3 hours for adults and 14.2 hours for children, and significantly increased antiviral treatment in adults. Risk of readmission or death was not significantly altered by a positive result. Testing for 26 respiratory pathogens established that risk of coinfection is lower with increasing age and that POCT for adults should be restricted to the influenza and RSV season.ConclusionPositive POCT resulted in changed patient management for both children and adults, and was deemed safe. POCT for additional pathogens may be beneficial in children below 5 years of age and outside the influenza and RSV season.
背景
2018 年,丹麦首都地区所有医院的急诊部都实施了针对甲型和乙型流感病毒以及呼吸道合胞病毒(RSV)的即时检测(POCT)。
目的
确定流感病毒或 RSV 的 POCT 是否基于有效的呼吸道症状指征,基于阳性结果改变患者管理是否安全,以及综合 POCT 是否可能使流感或 RSV 患者受益。
方法
2018 年 2 月至 7 月期间,使用 POCT 对 180 名儿童(<18 岁)和 375 名成年人进行了检测,对其中的 26 种呼吸道病原体样本进行了重新检测。从患者记录中获得了诊断、POCT 检测指征、住院时间、抗菌治疗以及检测后一个月内的再入院或死亡情况。
结果
168 名儿童(93.3%)和 334 名成年人(89.1%)的 POCT 检测有明确的指征。POCT 的阳性结果显著减少了成年人的抗生素处方和平均住院时间(44.3 小时),也减少了儿童的抗生素处方和平均住院时间(14.2 小时),并显著增加了成年人的抗病毒治疗。阳性结果并未显著改变再入院或死亡的风险。对 26 种呼吸道病原体的检测表明,随着年龄的增长,合并感染的风险降低,并且 POCT 对于成年人,应仅限于流感和 RSV 季节使用。
结论
POCT 阳性结果导致儿童和成年人的患者管理发生了改变,且被认为是安全的。对于 5 岁以下儿童和流感及 RSV 季节以外的时间,检测更多的病原体可能是有益的。